Hematology & Oncology

Division of Hematology and Oncology

U.S. News ranks Shands at UF among nation's best hospitals

The Department of Medicine had the highest ranking in Florida in three specialties: cardiology & heart surgery (tied for 27th nationally); pulmonology (28th nationally); and nephrology (tied for 35th nationally). DOM was also ranked in cancer (35th nationally) and gastroenterology (38th nationally). <Full article>

UF researchers find quiet protein speaks loudly in fight against cancer

When a movie character says, “It’s too quiet,” that’s usually a sign something bad may happen. Now, University of Florida researchers have discovered that when variations of a certain protein in our cells are too quiet, it may add to the risk that someone will develop lung cancer. When scientists restored the protein to its normal, active self, its cancer-inhibiting properties reappeared. <Full article>

UF hepatologists test chemotherapy pill in patients with advanced liver cancer, cirrhosis

Hepatologists at the University of Florida have begun a new clinical trial in search of a better way to treat patients who have advanced, inoperable primary liver cancer but have trouble tolerating standard doses of the only drug available to help them.

Funded through a $650,000 grant from Bayer HealthCare Pharmaceuticals Inc. and Onyx Pharmaceuticals Inc., the makers and marketers of Sorafenib — the only FDA-approved drug for advanced liver cancer — the six-month, randomized pilot study will evaluate whether patients with a dual diagnosis of cirrhosis and liver cancer are better able to tolerate the drug if given doses that differ from the manufacturer’s recommendation. <Click here for more info>

UF oncology doctor appointed chairman of state cancer council

Thomas J. George Jr., M.D., FACP, a University of Florida assistant professor of hematology and oncology, was recently tapped by Gov. Charles Crist to serve as chairman of the Florida Cancer Control and Research Advisory Council.  
<Click here for more info>

New UF Study Examines Patient Treatment Decisions for Colorectal Cancer

New UF Study Examines Patient Treatment Decisions for Colorectal CancerA new University of Florida study from a multidisciplinary team, including Dr. Thomas George, an oncologist and an assistant professor in the department of medicine, will take an in-depth look at the factors involved in treatment decisions made by people with colorectal cancer. The study is funded by a $1.2 million grant from Bankhead-Coley Florida Cancer Research Program, administered through the Florida Department of Health.
<Click here for more info>

Mission Statement:

The Division of Hematology and Oncology at the University of Florida is dedicated to the mitigation of suffering and death due to cancer and blood disorders through laboratory and clinical research-based patient care and education

Goals:

  • Become a national leader in the development of innovative and personalized therapeutics for patients with cancer and blood disorders
  • Deliver the highest quality clinical care to our patients through partnerships with national and local leaders and resources and through the provision of state-of-the-art clinical trials
  • Excel in the education of students, residents, fellows, nursing and other health related personnel, and practitioners of hematology-oncology regarding translational research and the art and science of administering to patients with cancer and blood disorders

 

 

Primary Navigation